Nantahala Capital Management LLC 13D and 13G filings for Inhibikase Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:40 pm Sale | 2026-06-30 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Nantahala Capital Management LLC | 5,810,487 4.300% | -1,227,429 (-17.44%) | Filing |
| 2026-02-13 5:04 pm Purchase | 2025-12-31 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Nantahala Capital Management LLC | 7,037,916 5.680% | 1,739,292 (+32.83%) | Filing |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Nantahala Capital Management LLC | 5,298,624 7.540% | 5,298,624 (New Position) | Filing |